MO
Matt O'Brien Piper Sandler Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
42
Avg Return
Past Year
Past Year
2.2%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
85.7%
Neutral
14.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Health Information Services
Medical Devices
Medical Distribution
Medical Instruments & Supplies
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Overweight
Reiterated
| $115 |
23%
upside
| 2 | +14% |
0
%
| 8 Jan ‘26 yesterday |
|
|
|
Overweight
Maintained
| $30 |
21%
upside
| 2 | +3.3% |
0
%
| 12 Dec ‘25 28 days ago |
|
|
|
Neutral
Reiterated
| $1.25 |
15%
upside
| 2 | -22% |
–
| 14 Nov ‘25 1 month ago |
|
|
|
Overweight
Reiterated
| $18 |
23%
upside
| 2 | +8.3% |
0
%
| 12 Nov ‘25 1 month ago |
|
|
|
Overweight
Maintained
| $55 |
29%
upside
| 2 | -7.8% |
0
%
| 6 Nov ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $50 |
52%
upside
| 2 | -15% |
0
%
| 5 Nov ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $75 |
11%
upside
| 3 | +0.61% |
0
%
| 31 Oct ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $25 |
10%
upside
| 3 | +29% |
0
%
| 31 Oct ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $140 |
2%
upside
| 4 | +12% |
0
%
| 30 Oct ‘25 2 months ago |
|
|
|
Overweight
Reiterated
| $32 |
56%
upside
| 2 | +2.2% |
0
%
| 29 Oct ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $82 |
3%
downside
| 1 | +14% |
0
%
| 24 Oct ‘25 2 months ago |
|
|
|
Overweight
Maintained
| $22 |
20%
upside
| 2 | -8.4% |
0
%
| 10 Oct ‘25 3 months ago |
|
|
|
Overweight
Initiated
| $38 |
14%
upside
| 1 | +7.6% |
0
%
| 2 Sep ‘25 4 months ago |
|
|
|
Overweight
Initiated
| $18 |
40%
upside
| 1 | -5.3% |
0
%
| 18 Aug ‘25 4 months ago |
|
|
|
Neutral
Downgraded
| $14 |
35%
downside
| 2 | -15% |
0
%
| 7 Aug ‘25 5 months ago |
|
|
|
Overweight
Maintained
| $12 |
45%
upside
| 2 | -23% |
0
%
| 9 May ‘25 8 months ago |
|
|
|
Overweight
Maintained
| $165 |
47%
upside
| 2 | -10% |
0
%
| 15 Apr ‘25 8 months ago |
|
|
|
Neutral
Maintained
| $3.50 |
51%
downside
| 1 | – |
–
| 6 Mar ‘25 10 months ago |
|
|
|
Neutral
Downgraded
| $140 |
25%
upside
| 1 | – |
–
| 28 Feb ‘25 10 months ago |
|
|
|
Overweight
Maintained
| $310 |
7%
upside
| 1 | +0.4% |
0
%
| 21 Feb ‘25 10 months ago |
|
|
|
Overweight
Reiterated
| $330 |
3%
upside
| 1 | +18% |
0
%
| 19 Feb ‘25 10 months ago |
|
|
|
Overweight
Maintained
| $50 |
18%
upside
| 1 | +0.35% |
0
%
| 13 Feb ‘25 11 months ago |
|
|
|
Neutral
Maintained
| $16 |
28%
downside
| 1 | – |
–
| 12 Feb ‘25 11 months ago |
|
|
|
Overweight
Maintained
| $115 |
18%
upside
| 1 | -4.5% |
0
%
| 3 Feb ‘25 11 months ago |
|